デフォルト表紙
市場調査レポート
商品コード
1660666

トランスフェクション技術市場レポート:製品タイプ、用途、トランスフェクション方法、技術、エンドユーザー、地域別、2025年~2033年

Transfection Technologies Market Report by Product Type, Application, Transfection Method, Technology, End-User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
トランスフェクション技術市場レポート:製品タイプ、用途、トランスフェクション方法、技術、エンドユーザー、地域別、2025年~2033年
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

トランスフェクション技術の世界市場規模は、2024年に12億5,890万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに23億3,870万米ドルに達し、2025年から2033年にかけて7.1%の成長率(CAGR)を示すと予測しています。

トランスフェクション技術とは、デオキシリボ核酸(DNA)、リボ核酸(RNA)、オリゴヌクレオチドなどの核酸を人工的に細胞に導入するプロセスを指します。核酸は様々な物理的、化学的、生物学的方法を用いて導入され、細胞の特定の性質を変化させるのに役立ちます。コトランスフェクション、エレクトロポレーション、カチオン性脂質トランスフェクション、インビボ・トランスフェクションなど様々な方法があります。このプロセスは、遺伝子発現、スクリーニング、RNA干渉、ウイルスやタンパク質の生物学的産生を含む様々なゲノム研究に一般的に使用されています。

がんや様々な慢性生活習慣病の有病率の増加は、市場の成長を促進する主な要因の一つです。さらに、試薬ベースの方法が広く採用されていることも、市場の成長を後押ししています。従来から使用されている手法と比較すると、試薬ベースのトランスフェクションは投与の手間がかからず、費用対効果も高いです。これに伴い、バイオリスティックテクノロジー、マイクロインジェクション、レーザーフェクションなどの機器ベースの手法も、世界中で絶大な支持を得ています。細胞研究や治療法の発見におけるさまざまな技術的進歩も、成長を促す大きな要因となっています。これに伴い、遺伝子導入の研究は、新規治療薬の開発やその他の様々な応用のために、主に生体内条件下で行われています。その他の要因としては、大規模なトランスフェクション施設を開発するための政府および民間組織による投資の増加、タンパク質治療薬分野における広範な研究開発(R&D)活動などがあり、市場をさらに牽引すると予測されています。

本レポートで扱う主な質問

  • 2024年の世界のトランスフェクション技術市場の市場規模は?
  • 2025-2033年の世界のトランスフェクション技術市場の予想成長率は?
  • 世界のトランスフェクション技術市場を牽引する主要因は何か?
  • 世界のトランスフェクション技術市場に対するCOVID-19の影響は?
  • 世界のトランスフェクション技術市場の製品タイプ別内訳は?
  • 世界のトランスフェクション技術市場の用途別内訳は?
  • 世界のトランスフェクション技術市場のトランスフェクション方法別内訳は?
  • 世界のトランスフェクション技術市場の技術別の内訳は?
  • 世界のトランスフェクション技術市場における主要地域は?
  • 世界のトランスフェクション技術市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のトランスフェクション技術市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品タイプ別

  • 試薬
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:用途別

  • 治療の実施
    • 市場動向
    • 市場予測
  • バイオメディカル研究
    • 市場動向
    • 市場予測
  • タンパク質生産
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:トランスフェクション方法別

  • リポフェクション
    • 市場動向
    • 市場予測
  • エレクトロポレーション
    • 市場動向
    • 市場予測
  • ヌクレオフェクション
    • 市場動向
    • 市場予測
  • 共トランスフェクション
    • 市場動向
    • 市場予測
  • カチオン脂質トランスフェクション
    • 市場動向
    • 市場予測
  • 生体内トランスフェクション
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:技術別

  • 物理的トランスフェクション
    • 市場動向
    • 市場予測
  • バイオケミカルベースのトランスフェクション
    • 市場動向
    • 市場予測
  • ウイルスベクターベースのトランスフェクション
    • 市場動向
    • 市場予測

第10章 市場内訳:エンドユーザー別

  • 研究センターおよび学術機関
    • 市場動向
    • 市場予測
  • 病院と診療所
    • 市場動向
    • 市場予測
  • 製薬・バイオテクノロジー企業
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-RAD Laboratories Inc.
    • Lonza Group AG
    • Maxcyte Inc.
    • Mirus Bio LLC
    • Polyplus Transfection
    • Promega Corporation
    • Roche Holding AG
    • Sigma-Aldrich Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Transfection Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Transfection Technologies Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Transfection Technologies Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Transfection Technologies Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Transfection Technologies Market: Breakup by Transfection Method (in %), 2024
  • Figure 6: Global: Transfection Technologies Market: Breakup by Technology (in %), 2024
  • Figure 7: Global: Transfection Technologies Market: Breakup by End-User (in %), 2024
  • Figure 8: Global: Transfection Technologies Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Transfection Technologies (Reagent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Transfection Technologies (Reagent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Transfection Technologies (Instrument) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Transfection Technologies (Instrument) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Transfection Technologies (Therapeutic Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Transfection Technologies (Therapeutic Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Transfection Technologies (Bio-Medical Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Transfection Technologies (Bio-Medical Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Transfection Technologies (Protein Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Transfection Technologies (Protein Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Transfection Technologies (Lipofection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Transfection Technologies (Lipofection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Transfection Technologies (Eletroporation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Transfection Technologies (Eletroporation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Transfection Technologies (Nucleofection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Transfection Technologies (Nucleofection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Transfection Technologies (Cotransfection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Transfection Technologies (Cotransfection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Transfection Technologies (Cationic Lipid Transfection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Transfection Technologies (Cationic Lipid Transfection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Transfection Technologies (In-Vivo Transfection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Transfection Technologies (In-Vivo Transfection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Transfection Technologies (Physical Transfection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Transfection Technologies (Physical Transfection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Transfection Technologies (Biochemical Based Transfection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Transfection Technologies (Biochemical Based Transfection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Transfection Technologies (Viral-Vector Based Transfection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Transfection Technologies (Viral-Vector Based Transfection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Transfection Technologies (Research Centers and Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Transfection Technologies (Research Centers and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: Transfection Technologies (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: Transfection Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: North America: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: North America: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United States: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United States: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Canada: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Canada: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Asia Pacific: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Asia Pacific: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: China: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: China: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Japan: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Japan: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: India: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: India: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: South Korea: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: South Korea: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Australia: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Australia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Indonesia: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Indonesia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Europe: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Europe: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Germany: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Germany: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: France: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: France: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: United Kingdom: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: United Kingdom: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Italy: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Italy: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Spain: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Spain: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Russia: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Russia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Others: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Latin America: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Latin America: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Brazil: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Brazil: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Mexico: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Mexico: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Others: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Middle East and Africa: Transfection Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 99: Middle East and Africa: Transfection Technologies Market: Breakup by Country (in %), 2024
  • Figure 100: Middle East and Africa: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Global: Transfection Technologies Industry: SWOT Analysis
  • Figure 102: Global: Transfection Technologies Industry: Value Chain Analysis
  • Figure 103: Global: Transfection Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transfection Technologies Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Transfection Technologies Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Transfection Technologies Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Transfection Technologies Market Forecast: Breakup by Transfection Method (in Million USD), 2025-2033
  • Table 5: Global: Transfection Technologies Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 6: Global: Transfection Technologies Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 7: Global: Transfection Technologies Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Transfection Technologies Market Structure
  • Table 9: Global: Transfection Technologies Market: Key Players
目次
Product Code: SR112025A2188

The global transfection technologies market size reached USD 1,258.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,338.7 Million by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033.

Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.

Key Market Segmentation:

Breakup by Product Type:

  • Reagent
  • Instrument
  • Others

Breakup by Application:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Breakup by Transfection Method:

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Breakup by Technology:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Breakup by End-User:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

  • 1.What was the size of the global transfection technologies market in 2024?
  • 2.What is the expected growth rate of the global transfection technologies market during 2025-2033?
  • 3.What are the key factors driving the global transfection technologies market?
  • 4.What has been the impact of COVID-19 on the global transfection technologies market?
  • 5.What is the breakup of the global transfection technologies market based on the product type?
  • 6.What is the breakup of the global transfection technologies market based on the application?
  • 7.What is the breakup of the global transfection technologies market based on the transfection method?
  • 8.What is the breakup of the global transfection technologies market based on the technology?
  • 9.What are the key regions in the global transfection technologies market?
  • 10.Who are the key players/companies in the global transfection technologies market?10. Who are the key players/companies in the global transfection technologies market?"

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transfection Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instrument
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bio-Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Protein Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Transfection Method

  • 8.1 Lipofection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eletroporation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nucleofection
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cotransfection
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Cationic Lipid Transfection
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 In-Vivo Transfection
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Physical Transfection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Based Transfection
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Viral-Vector Based Transfection
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Research Centers and Academic Institutes
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-RAD Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Lonza Group AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Maxcyte Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Mirus Bio LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Polyplus Transfection
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Promega Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Roche Holding AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Sigma-Aldrich Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis